GNS.L Stock Analysis
GN
Avoid
Based on Eyestock quantitative analysis, GNS.L`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Genus Plc engages in the provision of genetic livestock services to produce meat and milk. The company is headquartered in Basingstoke, Hampshire and currently employs 3,325 full-time employees. The company went IPO on 2000-07-06. The firm provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The firm operates through three segments: Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers to breed commercial pigs with desirable characteristics for pork production. The firm operates in approximately 25 countries on six continents, with research laboratories located in Madison, Wisconsin, United States.